BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37769631)

  • 1. Cerebrospinal Fluid Metabolomic Pattern of Different Pituitary Stalk Lesions.
    Wang L; Chen X; Liu X; Miao H; Gong F; Yang H; Duan L; Zhu H; Sun W
    J Clin Endocrinol Metab; 2024 Feb; 109(3):802-814. PubMed ID: 37769631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of neuroimaging features of histiocytic neoplasms with central nervous system involvement: a retrospective study of 121 adult patients.
    Fan X; Liu T; Zhang Z; Sun J; Niu N; Mao C; Wang F; Li J; Zhou D; Cao X; Jin Z; Feng F
    Eur Radiol; 2023 Nov; 33(11):8031-8042. PubMed ID: 37191919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dramatic efficacy of dabrafenib in Erdheim-Chester disease (ECD): a pediatric patient with multiple large intracranial ECD lesions hidden by refractory Langerhans cell histiocytosis.
    Hao X; Feng R; Bi Y; Liu Y; Li C; Lu T; Tian Y
    J Neurosurg Pediatr; 2018 Sep; 23(1):48-53. PubMed ID: 30265230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Central diabetes insipidus in adult patients--the first sign of Langerhans cell histiocytosis and Erdheim-Chester disease. Three case studies and literature review].
    Adam Z; Balsíková K; Krejcí M; Pour L; Stĕpánková S; Svacina P; Hermanová M; Vanícek J; Krupa P; Stanícek J; Koukalová R; Neubauer J; Krivanová A; Mayer J; Hájek R
    Vnitr Lek; 2010 Feb; 56(2):138-48. PubMed ID: 20329585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hand-Schüller-Christian disease and Erdheim-Chester disease: coexistence and discrepancy.
    Yin J; Zhang F; Zhang H; Shen L; Li Q; Hu S; Tian Q; Bao Y; Jia W
    Oncologist; 2013; 18(1):19-24. PubMed ID: 23299772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation.
    Hervier B; Haroche J; Arnaud L; Charlotte F; Donadieu J; Néel A; Lifermann F; Villabona C; Graffin B; Hermine O; Rigolet A; Roubille C; Hachulla E; Carmoi T; Bézier M; Meignin V; Conrad M; Marie L; Kostrzewa E; Michot JM; Barete S; Taly V; Cury K; Emile JF; Amoura Z;
    Blood; 2014 Aug; 124(7):1119-26. PubMed ID: 24894769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexistence of intracranial Langerhans cell histiocytosis and Erdheim-Chester disease in a pediatric patient: a case report.
    Kim S; Lee M; Shin HJ; Lee J; Suh YL
    Childs Nerv Syst; 2016 May; 32(5):893-6. PubMed ID: 26466952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An unusual case of Erdheim-Chester disease with features of Langerhans cell histiocytosis.
    Furmanczyk PS; Bruckner JD; Gillespy T; Rubin BP
    Skeletal Radiol; 2007 Sep; 36(9):885-9. PubMed ID: 17492445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathological and Clinical Findings in Cutaneous Manifestation of Erdheim-Chester Disease and Langerhans Cell Histiocytosis Overlap Syndrome Associated With the BRAFV600E Mutation.
    Liersch J; Carlson JA; Schaller J
    Am J Dermatopathol; 2017 Jul; 39(7):493-503. PubMed ID: 27898473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characterization of Endocrine Glands Involved in Erdheim-Chester Disease].
    Tang Y; Wu Z; Wei ZM; Sun H; Jin ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Jun; 44(3):428-432. PubMed ID: 35791940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical spectrum and prognostic factors of Erdheim-Chester disease and mixed Langerhans cell histiocytosis and Erdheim-Chester disease.
    Dai JW; Lin H; Chang L; Li J; Zhou DB; Cao XX
    Ann Hematol; 2023 Dec; 102(12):3335-3343. PubMed ID: 37922006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [MR-documented remission of pituitary stalk infiltration in patients with Langerhans cell histiocytosis following treatment with 2-chlorodeoxyadenosine].
    Vanícek J; Adam Z; Balsíková K; Krejcí M; Pour L; Szturz P; Zahradová L; Hájek R; Koukalová R; Rehák Z; Král Z; Mayer J
    Vnitr Lek; 2011 Oct; 57(10):871-5. PubMed ID: 22097697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed Langerhans Cell Histiocytosis and Erdheim-Chester Disease in a Girl: A Rare and Puzzling Diagnosis.
    Ocak S; Bayramoglu Z; Tugcu D; Karaman S; Unuvar A; Karakas Z
    J Pediatr Hematol Oncol; 2021 Apr; 43(3):e375-e379. PubMed ID: 32097280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated Langerhans cell histiocytosis in the hypothalamic-pituitary region: a case report.
    Zhou W; Rao J; Li C
    BMC Endocr Disord; 2019 Dec; 19(1):143. PubMed ID: 31856773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Associated Langerhans cell histiocytosis and Erdheim-Chester disease].
    Marchal A; Cuny JF; Montagne K; Haroche J; Barbaud A; Schmutz JL
    Ann Dermatol Venereol; 2011 Nov; 138(11):743-7. PubMed ID: 22078035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Langerhans cell histiocytosis and Erdheim-Chester disease.
    Wilejto M; Abla O
    Curr Opin Rheumatol; 2012 Jan; 24(1):90-6. PubMed ID: 22157416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.
    Perić P; Antić B; Knezević-Usaj S; Radić-Tasić O; Radovinović-Tasić S; Vasić-Vilić J; Sekulović L; Tarabar O; Tukić L; Jovandić S; Magić Z
    Vojnosanit Pregl; 2016 Jan; 73(1):83-7. PubMed ID: 26964390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of Erdheim-Chester disease and Langerhans cell histiocytosis in the same patient: a report of 2 cases.
    Pineles SL; Liu GT; Acebes X; Arruga J; Nasta S; Glaser R; Pramick M; Fogt F; Roux PL; Gausas RE
    J Neuroophthalmol; 2011 Sep; 31(3):217-23. PubMed ID: 21326112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin is highly secreted in the cerebrospinal fluid of patient with posterior pituitary involvement in Langerhans cell histiocytosis.
    Li N; Cui L; Ma H; Gong Z; Lian H; Wang C; Zhang Q; Zhao X; Chen X; Tian Y; Yang Y; Wei A; Zhang R; Li Z; Wang T
    Int J Lab Hematol; 2020 Dec; 42(6):788-795. PubMed ID: 32845092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study.
    Diamond EL; Subbiah V; Lockhart AC; Blay JY; Puzanov I; Chau I; Raje NS; Wolf J; Erinjeri JP; Torrisi J; Lacouture M; Elez E; Martínez-Valle F; Durham B; Arcila ME; Ulaner G; Abdel-Wahab O; Pitcher B; Makrutzki M; Riehl T; Baselga J; Hyman DM
    JAMA Oncol; 2018 Mar; 4(3):384-388. PubMed ID: 29188284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.